1. DL-3-n-butylphthalide alleviates motor disturbance by suppressing ferroptosis in a rat model of Parkinson’s disease
   Li-Hua Shen et al, 2023, Neural Regeneration Research CrossRef
2. TBBPA induces inflammation, apoptosis, and necrosis of skeletal muscle in mice through the ROS/Nrf2/TNF-α signaling pathway
   Qirui Zhang et al, 2023, Environmental Pollution CrossRef
3. Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: Correlation between Nrf2 and HMGB1/TLR4/PI3K/Akt/mTOR signaling
   Rehab M. El-Sayed et al, 2023, International Immunopharmacology CrossRef
4. A novel protective modality against rotenone-induced Parkinson's disease: A pre-clinical study with dulaglutide
   Marwa M. Khalaf et al, 2023, International Immunopharmacology CrossRef
5. Vincamine alleviates brain injury by attenuating neuroinflammation and oxidative damage in a mouse model of Parkinson's disease through the NF‐κB and Nrf2/HO‐1 signaling pathways
   Pengjun Wang et al, 2024, Journal of Biochemical and Molecular Toxicology CrossRef
6. Vitamin B12 Ameliorates the Pathological Phenotypes of Multiple Parkinson’s Disease Models by Alleviating Oxidative Stress
   Yue Wu et al, 2023, Antioxidants CrossRef
7. Effect of Dl-3-n-Butylphthalide on olfaction in rotenone-induced Parkinson’s rats
   Jiawei Wang et al, 2024, Frontiers in Neurology CrossRef
8. Butylphthalide improves brain damage induced by renal ischemia-reperfusion injury rats through Nrf2/HO-1 and NOD2/MAPK/NF-κB pathways
   Jingjing Min et al, 2023, Renal Failure CrossRef
9. miR-128-3p is involved in aluminum-induced cognitive impairment by regulating the Sirt1-Keap1/Nrf2 pathway
   Huan Li et al, 2024, Ecotoxicology and Environmental Safety CrossRef
10. PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in rats
    Heba A. Farid et al, 2024, Inflammopharmacology CrossRef
11. 3-N-butylphthalide attenuates neuroinflammation in rotenone-induced Parkinson’s disease models via the cGAS-STING pathway
    Yuqian Liu et al, 2024, International Journal of Immunopathology and Pharmacology CrossRef